Sumant Kulkarni Analyst Performance

Sumant Kulkarni is a stock analyst at Canaccord Genuity Group in the medical sector, covering 23 publicly traded companies. Over the past year, Sumant Kulkarni has issued 20 stock ratings, including buy and hold recommendations. While full access to Sumant Kulkarni's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sumant Kulkarni's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

99 Last 11 Years

Buy Recommendations

81.44% 79 Buy Ratings

Companies Covered

23 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	81.4%	79 ratings
Hold	17.5%	17 ratings
Sell	1.0%	1 ratings

Out of 97 total stock ratings issued by Sumant Kulkarni at Canaccord Genuity Group, the majority (81.4%) have been Buy recommendations, followed by 17.5% Hold and 1.0% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  BTAI

  Mar 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  BHC

  Dec 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	78.3% of companies on NASDAQ	18 companies
NYSE	21.7% of companies on NYSE	5 companies

Sumant Kulkarni, an analyst at Canaccord Genuity Group, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 23 companies	100.0%

Sumant Kulkarni of Canaccord Genuity Group specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 10 companies	43.5%
PHARMACEUTICAL PREPARATIONS 6 companies	26.1%
MED - DRUGS 2 companies	8.7%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 2 companies	8.7%
MEDICAL SERVICES 1 company	4.3%
MED - OUTP/HM CRE 1 company	4.3%
MED - GENERIC DRG 1 company	4.3%

Sumant Kulkarni's Ratings History at Canaccord Genuity Group

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
CLNN Clene	8/18/2025	Lower Price Target	$3.62	$48.00	Buy	$0.00 00.00% ROI
CMPS COMPASS Pathways	8/1/2025	Reiterated Rating	$4.36	$15.00	Buy	$0.00 00.00% ROI
CRVO CervoMed	7/29/2025	Boost Price Target	$8.55	$27.00	Buy	$0.00 00.00% ROI
ATAI atai Life Sciences	7/28/2025	Lower Price Target	$3.27	$11.00	Buy	$0.00 00.00% ROI
CYBN Cybin	7/8/2025	Lower Price Target	$7.62	$70.00	Buy	$0.00 00.00% ROI
ATAI atai Life Sciences	7/2/2025	Boost Price Target	$2.73	$12.00	Buy	$0.00 00.00% ROI
SAGE Sage Therapeutics	6/17/2025	Boost Price Target	$9.07	$8.50	Hold	$0.00 00.00% ROI
ANVS Annovis Bio	5/15/2025	Lower Price Target	$1.71	$17.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	5/6/2025	Boost Price Target	$109.75	$160.00	Buy	$0.00 00.00% ROI
BIIB Biogen	5/2/2025	Lower Price Target	$123.25	$220.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	4/28/2025	Lower Price Target	$106.73	$158.00	Buy	$0.00 00.00% ROI
CRVO CervoMed	3/18/2025	Boost Price Target	$9.05	$21.00	Buy	$0.00 00.00% ROI
VYGR Voyager Therapeutics	3/13/2025	Lower Price Target	$4.03	$12.00	Buy	$0.00 00.00% ROI
ZVRA Zevra Therapeutics	3/13/2025	Boost Price Target	$7.98	$25.00	Buy	$0.00 00.00% ROI
CMPS COMPASS Pathways	2/28/2025	Lower Price Target	$3.96	$15.00	Buy	$0.00 00.00% ROI
BIIB Biogen	2/13/2025	Lower Price Target	$133.43	$265.00	Buy	$0.00 00.00% ROI
SAGE Sage Therapeutics	2/12/2025	Lower Price Target	$7.19	$8.00	Hold	$0.00 00.00% ROI
CYBN Cybin	2/12/2025	Lower Price Target	$9.39	$73.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	2/7/2025	Lower Price Target	$124.12	$163.00	Buy	$0.00 00.00% ROI
ITCI Intra-Cellular Therapies	1/31/2025	Downgrade	$127.00	$132.00	Hold	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.